The Valley Desk

NCT00168740 · Interventional trial

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

Overall registry status Completed

Phase 3

Conditions Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov